Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.
about
Drug-induced liver injury: recent advances in diagnosis and risk assessment.Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or NecrosisAdverse drug reactions triggered by the common HLA-B*57:01 variant: virtual screening of DrugBank using 3D molecular docking.Biomarkers of adverse drug reactions.Minocycline-Induced Autoimmune Hepatitis: A Rare But Important Cause of Drug-Induced Autoimmune Hepatitis
P2860
Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Minocycline hepatotoxicity: Cl ...... HLA-B∗35:02 as a risk factor.
@en
type
label
Minocycline hepatotoxicity: Cl ...... HLA-B∗35:02 as a risk factor.
@en
prefLabel
Minocycline hepatotoxicity: Cl ...... HLA-B∗35:02 as a risk factor.
@en
P2093
P2860
P50
P1476
Minocycline hepatotoxicity: Cl ...... HLA-B∗35:02 as a risk factor.
@en
P2093
Andrew Stolz
David Ostrov
Drug-Induced Liver Injury Network (DILIN)
Elizabeth Trilby Cirulli
Huiman Barnhart
International Serious Adverse Events Consortium (iSAEC)
Joseph Odin
José Serrano
Naga Chalasani
Nanye Long
P2860
P304
P356
10.1016/J.JHEP.2017.03.010
P407
P577
2017-03-17T00:00:00Z